Thomas William Burns Glaukos Corp (GKOS) insider trading activity

Thomas William Burns is CHAIRMAN & CEO of GLAUKOS Corp. Currently has a direct ownership of 88,494 shares of GKOS, which is worth approximately $11.4 Million. The most recent transaction as insider was on Sep 19, 2024, when has been sold 8,336 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.5K

8.96% 3M change

61.53% 12M change

Total Value Held $11.4 Million

Thomas William Burns Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 19 2024	BUY Grant, award, or other acquisition	-	8,336 Added 8.61%	88,494 Common Stock
Aug 06 2024	SELL Payment of exercise price or tax liability	$127,611 $120.73 p/Share	1,057 Reduced 1.3%	80,158 Common Stock
Jun 24 2024	SELL Payment of exercise price or tax liability	$98,531 $93.13 p/Share	1,058 Reduced 1.29%	81,215 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$363,741 $93.1 p/Share	3,907 Reduced 4.53%	82,273 Common Stock
Mar 28 2024	SELL Payment of exercise price or tax liability	$566,609 $87.86 p/Share	6,449 Reduced 6.96%	86,180 Common Stock
Mar 25 2024	SELL Payment of exercise price or tax liability	$143,057 $90.2 p/Share	1,586 Reduced 1.68%	92,629 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	38,777 Added 29.16%	94,215 Common Stock
Jan 12 2024	SELL Payment of exercise price or tax liability	$30,600 $77.08 p/Share	397 Reduced 0.71%	55,438 Common Stock
Jan 09 2024	SELL Open market or private sale	$9,931 $86.36 p/Share	115 Reduced 0.21%	55,835 Common Stock
Jan 09 2024	BUY Exercise of conversion of derivative security	$837 $7.28 p/Share	115 Added 0.21%	55,950 Common Stock
Jan 08 2024	SELL Open market or private sale	$4,945,200 $82.42 p/Share	60,000 Reduced 51.8%	55,835 Common Stock
Jan 08 2024	BUY Exercise of conversion of derivative security	$436,800 $7.28 p/Share	60,000 Added 34.12%	115,835 Common Stock
Jan 02 2024	SELL Open market or private sale	$7,372,950 $77.61 p/Share	95,000 Reduced 62.98%	55,835 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$691,600 $7.28 p/Share	95,000 Added 38.64%	150,835 Common Stock
Dec 22 2023	SELL Open market or private sale	$85 $85.32 p/Share	1 Reduced 0.0%	55,835 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	$7 $7.28 p/Share	1 Added 0.0%	55,836 Common Stock
Dec 21 2023	SELL Open market or private sale	$6,789,873 $85.21 p/Share	79,684 Reduced 58.8%	55,835 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$580,099 $7.28 p/Share	79,684 Added 37.03%	135,519 Common Stock
Dec 15 2023	SELL Open market or private sale	$4,869,000 $81.15 p/Share	60,000 Reduced 51.8%	55,835 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$436,800 $7.28 p/Share	60,000 Added 34.12%	115,835 Common Stock
Dec 14 2023	SELL Open market or private sale	$2,279,400 $75.98 p/Share	30,000 Reduced 34.95%	55,835 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$218,400 $7.28 p/Share	30,000 Added 25.9%	85,835 Common Stock
Dec 08 2023	BUY Grant, award, or other acquisition	-	2,084 Added 3.6%	55,835 Common Stock
Nov 10 2023	SELL Payment of exercise price or tax liability	$71,170 $68.83 p/Share	1,034 Reduced 1.89%	53,751 Common Stock
Oct 02 2023	SELL Open market or private sale	$3,266,999 $72.6 p/Share	45,000 Reduced 45.1%	54,785 Common Stock

Also insider at

LUNG

Pulmonx Corp Healthcare

TWB